Results 91 to 100 of about 467,750 (151)

Partial deficiency of ornithine transcarbamylase. A case report [PDF]

Farmacia Hospitalaria, 2014
M. Pellicer Corbí, C. Herranz Muñoz, G. Baldominos Utrilla, M. Fernández-Pacheco García-Valdecasas   +3 more
doaj   +1 more source

Acute hyperammonemic encephalopathy masquerading as postoperative delirium in a patient who underwent lung surgery: a case report

BMC Anesthesiology
Background Acute hyperammonemic encephalopathy (AHE) is a life-threatening condition. Hyperammonemia-induced mental disorders that appear after surgery and general anesthesia can be easily confused with postoperative delirium, especially in patients ...
Chao-Qin Chen, Zhen-Ping Hu, Xu-Jie Ma, Xiao-Dong Tang, Xia Zheng, Yong-Xing Yao   +5 more
doaj   +1 more source

Reply to "The Role of Aquaporin 9 in Modeling of Ornithine Transcarbamylase Deficiency". [PDF]

, 2022
Häberle, Johannes, Willenbring, Holger, Laemmle, Alexander, Laemmle, Alexander; https://orcid.org/, Häberle, Johannes; https://orcid.org/, Willenbring, Holger; https://orcid.org/, Johannes Häberle, Alexander Laemmle, Holger Willenbring   +8 more
core   +2 more sources

Fatal Late-Onset Ornithine Transcarbamylase Deficiency in an Adolescent: A Case Report. [PDF]

Cureus
Christou E, Ntouzepi K, Machaira M, Tziouvas K, Patsoura A.   +4 more
europepmc   +1 more source

Ornithine transcarbamylase deficiency: A diagnostic odyssey. [PDF]

J Inherit Metab Dis, 2022
Knerr I, Cassiman D.
europepmc   +1 more source

Late-onset ornithine transcarbamylase deficiency with neurological damage and serial brain multimodality monitoring: a case report. [PDF]

Front Med (Lausanne)
Zhou Y, Liu Y, Zhou Y, Cao Y.
europepmc   +1 more source

The remarkable journey of one female individual with ornithine transcarbamylase deficiency diagnosed post-mortem. [PDF]

JIMD Rep, 2023
Forsyth R, Peretz RH, Dempsey A, Britton J, Kratz L, Hamosh A, Vernon H, Batshaw ML, Valle D.   +8 more
europepmc   +1 more source

A Complex Case of Ornithine Transcarbamylase Deficiency in a Patient With Severe Comorbid Conditions. [PDF]

Clin Case Rep
Khan M, Rafique SA, Khan S, Shah A, Karan A, Khalid AA, Afridi A, Tamim H, Talukder MRT.   +8 more
europepmc   +1 more source

Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice. [PDF]

Mol Ther Nucleic Acids, 2023
Yamazaki K, Kubara K, Ishii S, Kondo K, Suzuki Y, Miyazaki T, Mitsuhashi K, Ito M, Tsukahara K.   +8 more
europepmc   +1 more source

Rapamycin nanoparticles mitigate anti-AAV antibody formation in a mouse model of ornithine transcarbamylase deficiency. [PDF]

Mol Ther Adv
Vicidomini A, Boisgerault F, Romano G, Guarnaccia C, Vidal P, Collaud F, Soria LR, de Sabbata G, Tedesco N, Lisjak M, Saxena H, Camparini L, Iaconcig A, Moretti L, Skoko N, Ilyinskii P, Brunetti-Pierri N, Bortolussi G, Ronzitti G, Kishimoto TK, Muro AF.   +20 more
europepmc   +1 more source